BR.#

Related by string. * * BR.# study *

Related by context. Frequent words. (Click for all words.) 71 double blinded placebo 69 Amrubicin 69 phase IIb clinical 69 relapsed refractory multiple myeloma 68 placebo controlled clinical 68 prospective multicenter 68 Pivotal Phase III 67 plus gemcitabine 67 Pivotal Phase 66 Phase Ib clinical 66 metastatic renal cell carcinoma 65 multicenter clinical 65 Gynecologic Oncology Group 65 Metastatic Melanoma 65 pertuzumab 65 prospective observational 64 placebo controlled Phase 64 Phase 1b clinical 64 Phase III randomized 64 R sorafenib tablets 64 multicenter randomized double 64 randomized Phase III 64 HER2 positive metastatic breast 64 plus dexamethasone 64 tanespimycin 64 malignant pleural mesothelioma 64 phase IIa 64 relapsing multiple sclerosis 63 phase IIb 63 Pivotal Trial 63 neoadjuvant 63 Gemzar ® 63 Taxotere ® 63 superficial bladder cancer 63 Multicenter 63 heavily pretreated 63 refractory multiple myeloma 63 DCVax R Brain 63 axitinib 63 hepatocellular carcinoma HCC 63 relapsed multiple myeloma 63 metastatic hormone refractory 63 Phase 2b clinical 63 elotuzumab 63 decitabine 63 adecatumumab 63 OncoVEX GM CSF 62 RRMS patients 62 Completes Enrollment 62 nonrandomized 62 romidepsin 62 Epratuzumab 62 GSK# [001] 62 Cloretazine R VNP#M 62 Traficet EN 62 NSABP 62 mRCC 62 Phase III Clinical Trial 62 nab paclitaxel 62 Acute Myocardial Infarction 62 liposomal formulation 62 CCX# 61 hepatitis C HCV 61 active comparator 61 PEG SN# 61 Voreloxin 61 aflibercept 61 TELCYTA 61 multicenter randomized 61 Irinotecan 61 NCT# 61 Pirfenidone 61 Phase 2a clinical 61 KRN# 61 anticancer compound 61 TORISEL 61 mTOR inhibitor 61 registrational 61 placebo controlled randomized 61 abiraterone acetate 61 ponatinib 61 TRISENOX 61 label multicenter 61 Dasatinib 61 REVLIMID lenalidomide 61 Azedra 61 deforolimus 61 SABCS 61 SCH # 61 Phase 1b 61 non squamous 61 registrational trial 61 Phase 2b study 61 PRECiSE 61 dacarbazine 61 Metastatic Colorectal Cancer 61 TYKERB 61 glufosfamide 61 dose cohorts 60 cutaneous T cell 60 Clinical Trial Results

Back to home page